Andrzej Madej

Head

Wroclaw University of Science and Technology

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrzej Madej is the Head at the Katowice School of Technology in Poland. His research primarily focuses on the effects of various medical treatments and technologies, including the impact of metformin on plasma prolactin levels, the outcomes of assisted reproductive technology, and the efficacy of SGLT2 inhibitors in heart failure. His recent publications also cover significant topics such as the assessment of risks associated with congenital defects and the management of COVID-19 in patients on statins.

Articles (9)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Bartosz Czuba

Medical University of Silesia

POLAND

View details

Emilia Morawiec

Assistant professor

Academy of Silesia

POLAND

View details

Robert Krysiak

Medical University of Silesia

POLAND

View details

Bogusław Okopień

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrzej Madej

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

The Effect of Metformin on Plasma Prolactin Levels in Young Women with Autoimmune Thyroiditis

A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription–Polymerase Chain Reaction Tests For SARS-CoV-2 from a Single Laboratory in Katowice, Poland from April 2020 to July 2022

Evaluation of the risk of birth defects related to the use of assisted reproductive technology: an updated systematic review.

Risk Assessment of the Increased Occurrence of Congenital Cardiac and Non-Cardiac Defects in Fetuses with a Normal Karyotype after Assisted Fertilization in Comparison to Natural Fertilization Based on Ultrasound Diagnostics

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.

Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients.

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

OUTCOMES IN TREATMENT OF EUROPEAN (EU) PATIENTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP) COMPARING DELAFLOXACIN (DLX) AND MOXIFLOXACIN (MOX)

Collaborators (4)

Bartosz Czuba

Emilia Morawiec

Robert Krysiak

Bogusław Okopień

Make your next move.